🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
25.37
-1.14 (-4.30%)
At close: Nov 20, 2026, 4:00 PM EST
25.42
+0.05 (0.20%)
After-hours: Nov 20, 2026, 7:30 PM EST

Alto Neuroscience Statistics

Total Valuation

ANRO has a market cap or net worth of $1.02 billion. The enterprise value is $716.28 million.

Market Cap1.02B
Enterprise Value 716.28M

Important Dates

The last earnings date was Tuesday, November 10, 2026, after market close.

Earnings Date Nov 10, 2026
Ex-Dividend Date n/a

Share Statistics

ANRO has 40.11 million shares outstanding. The number of shares has increased by 49.21% in one year.

Current Share Class 40.11M
Shares Outstanding 40.11M
Shares Change (YoY) +49.21%
Shares Change (QoQ) +8.68%
Owned by Insiders (%) 2.45%
Owned by Institutions (%) 81.04%
Float 30.46M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.42
P/TBV Ratio 3.43
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 18.12, with a Debt / Equity ratio of 0.06.

Current Ratio 18.12
Quick Ratio 17.90
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -48.48

Financial Efficiency

Return on equity (ROE) is -46.65% and return on invested capital (ROIC) is -27.71%.

Return on Equity (ROE) -46.65%
Return on Assets (ROA) -26.54%
Return on Invested Capital (ROIC) -27.71%
Return on Capital Employed (ROCE) -32.57%
Weighted Average Cost of Capital (WACC) 12.14%
Revenue Per Employee n/a
Profits Per Employee -$1.40M
Employee Count68
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +63.26% in the last 52 weeks. The beta is 1.45, so ANRO's price volatility has been higher than the market average.

Beta (5Y) 1.45
52-Week Price Change +63.26%
50-Day Moving Average 25.58
200-Day Moving Average 25.00
Relative Strength Index (RSI) 48.54
Average Volume (20 Days) 624,050

Short Selling Information

The latest short interest is 5.68 million, so 14.17% of the outstanding shares have been sold short.

Short Interest 5.68M
Short Previous Month 4.66M
Short % of Shares Out 14.17%
Short % of Float 18.65%
Short Ratio (days to cover) 9.03

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -100.55M
Pretax Income -95.18M
Net Income -95.18M
EBITDA -99.84M
EBIT -100.55M
Earnings Per Share (EPS) -$2.36
Full Income Statement

Balance Sheet

The company has $319.34 million in cash and $18.02 million in debt, with a net cash position of $301.32 million or $7.51 per share.

Cash & Cash Equivalents 319.34M
Total Debt 18.02M
Net Cash 301.32M
Net Cash Per Share $7.51
Equity (Book Value) 296.53M
Book Value Per Share 7.42
Working Capital 305.36M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$79.12 million and capital expenditures -$556,000, giving a free cash flow of -$79.68 million.

Operating Cash Flow -79.12M
Capital Expenditures -556,000
Depreciation & Amortization 706,000
Net Borrowing n/a
Free Cash Flow -79.68M
FCF Per Share -$1.99
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ANRO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -49.21%
Shareholder Yield -49.21%
Earnings Yield -9.31%
FCF Yield -7.83%

Analyst Forecast

The average price target for ANRO is $38.67, which is 52.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target $38.67
Price Target Difference 52.42%
Analyst Consensus Strong Buy
Analyst Count 11
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3